Santa Monica and Los Angeles, Calif.; Boston, Mass.; St. Louis, Mo.; and Ann Arbor, Mich.
From RAND Health and Pardee RAND Graduate School, RAND Corporation; the Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine at UCLA; Body Aesthetic Plastic Surgery and Skincare Center; and the Section of Plastic Surgery, Department of Surgery, University of Michigan Health System.
Received for publication February 14, 2011; accepted March 22, 2011.
Disclosure:Support for this study was provided by the Plastic Surgery Foundation and the Aesthetic Surgery Education and Research Foundation through unrestricted grants from Allergan, L.L.C.; Mentor Worldwide, L.L.C.; and Sientra, Inc. Neither the study sponsors nor the listed companies had roles in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the article. None of the authors has a financial interest in any of the products or devices mentioned in this article.
The views, opinions, and techniques set forth in this article addressing anaplastic large cell lymphoma in women with breast implants are those of the individual author(s) and do not reflect the views, opinions, or recommendations of the American Society of Plastic Surgeons, the Journal, or the Journal editors. Any treatment recommendations contained in the article are those of the individual author(s) and are not to be considered or construed as practice guidelines, practice standards, or practice parameters. The use of any treatment technique described in the article is at the sole discretion of the physician in the exercise of his or her independent medical judgment taking into account the patient's individual circumstances.
Soeren Mattke, M.D., D.Sc.; RAND Corporation, 20 Park Plaza, Suite 720, Boston, Mass. 02116, [email protected]
